Phase 2 Metastatic Pancreatic Cancer Clinical Trials
25 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 25 trials
Recruiting
Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Metastatic Breast CarcinomaMetastatic Ovarian CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI)332 enrolled1 locationNCT01174121
Recruiting
Phase 1Phase 2
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Metastatic Pancreatic CancerPancreatic AdenocarcinomaBasal Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center104 enrolled1 locationNCT06483555
Recruiting
Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
Endometrial CancerLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+10 more
Rahul Aggarwal89 enrolled3 locationsNCT03682289
Recruiting
Phase 2
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
Metastatic Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle162 enrolled8 locationsNCT05065801
Recruiting
Phase 1Phase 2
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
Metastatic Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma+1 more
Mayo Clinic40 enrolled1 locationNCT04605913
Recruiting
Phase 2
Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School56 enrolled1 locationNCT06662006
Recruiting
Phase 2
QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital33 enrolled1 locationNCT06951997
Recruiting
Phase 1Phase 2
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd.60 enrolled1 locationNCT07296341
Recruiting
Phase 2Phase 3
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Hutchmed502 enrolled2 locationsNCT06361888
Recruiting
Phase 2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins38 enrolled1 locationNCT04753879
Recruiting
Phase 2
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
Metastatic Pancreatic CancerMetastatic Pancreatic Ductal Adenocarcinoma
Benjamin Spieler20 enrolled1 locationNCT06843551
Recruiting
Phase 2
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
Metastatic Pancreatic Cancer
National Cancer Centre, Singapore50 enrolled1 locationNCT05929885
Recruiting
Phase 2
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
Hyperthermic Intraperitoneal ChemotherapyPeritoneal Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital90 enrolled2 locationsNCT06946901
Recruiting
Phase 1Phase 2
Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
Locally Advanced or Metastatic Pancreatic Cancer
BeyondBio Inc.75 enrolled1 locationNCT03579836
Recruiting
Phase 1Phase 2
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
Metastatic Pancreatic Cancer
Joachim Aerts, MD PhD43 enrolled1 locationNCT05927142
Recruiting
Phase 1Phase 2
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic CancerMetastatic Prostate Cancer
ImmunoGenesis71 enrolled1 locationNCT06782555
Recruiting
Phase 1Phase 2
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
Metastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
Fujian Provincial Hospital29 enrolled4 locationsNCT06761027
Recruiting
Phase 1Phase 2
Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
Metastatic Pancreatic CancerAdebrelimab (SHR-1316)Decitabine
Tianjin Medical University Cancer Institute and Hospital20 enrolled1 locationNCT06454448
Recruiting
Phase 1Phase 2
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Cantex Pharmaceuticals30 enrolled6 locationsNCT05766748
Recruiting
Phase 2
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Metastatic Pancreatic CancerTerminal Cancer
Fudan University20 enrolled1 locationNCT06018896